image
Healthcare - Medical - Diagnostics & Research - NASDAQ - IE
$ 150.83
-1.88 %
$ 12.2 B
Market Cap
15.83
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ICLR stock under the worst case scenario is HIDDEN Compared to the current market price of 151 USD, ICON Public Limited Company is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ICLR stock under the base case scenario is HIDDEN Compared to the current market price of 151 USD, ICON Public Limited Company is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ICLR stock under the best case scenario is HIDDEN Compared to the current market price of 151 USD, ICON Public Limited Company is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ICLR

image
$300.0$300.0$280.0$280.0$260.0$260.0$240.0$240.0$220.0$220.0$200.0$200.0$180.0$180.0$160.0$160.0$140.0$140.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
8.28 B REVENUE
1.99%
1.1 B OPERATING INCOME
14.82%
791 M NET INCOME
29.26%
1.29 B OPERATING CASH FLOW
10.82%
-267 M INVESTING CASH FLOW
-17.71%
-837 M FINANCING CASH FLOW
0.81%
2.04 B REVENUE
0.55%
297 M OPERATING INCOME
4.06%
260 M NET INCOME
31.89%
338 M OPERATING CASH FLOW
-15.98%
-68.9 M INVESTING CASH FLOW
44.60%
-404 M FINANCING CASH FLOW
-313.14%
Balance Sheet ICON Public Limited Company
image
Current Assets 3.53 B
Cash & Short-Term Investments 539 M
Receivables 2.69 B
Other Current Assets 303 M
Non-Current Assets 13.3 B
Long-Term Investments 57.9 M
PP&E 530 M
Other Non-Current Assets 12.8 B
3.19 %15.93 %3.14 %75.60 %Total Assets$16.9b
Current Liabilities 2.8 B
Accounts Payable 173 M
Short-Term Debt 29.8 M
Other Current Liabilities 2.59 B
Non-Current Liabilities 4.56 B
Long-Term Debt 3.54 B
Other Non-Current Liabilities 1.02 B
35.26 %48.08 %13.89 %Total Liabilities$7.4b
EFFICIENCY
Earnings Waterfall ICON Public Limited Company
image
Revenue 8.28 B
Cost Of Revenue 5.85 B
Gross Profit 2.44 B
Operating Expenses 1.34 B
Operating Income 1.1 B
Other Expenses 306 M
Net Income 791 M
9b9b8b8b7b7b6b6b5b5b4b4b3b3b2b2b1b1b008b(6b)2b(1b)1b(306m)791mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
29.42% GROSS MARGIN
29.42%
13.26% OPERATING MARGIN
13.26%
9.56% NET MARGIN
9.56%
8.31% ROE
8.31%
4.69% ROA
4.69%
7.08% ROIC
7.08%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ICON Public Limited Company
image
1b1b1b1b800m800m600m600m400m400m200m200m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 791 M
Depreciation & Amortization 512 M
Capital Expenditures -168 M
Stock-Based Compensation 45.9 M
Change in Working Capital -18.8 M
Others -72.1 M
Free Cash Flow 1.12 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets ICON Public Limited Company
image
Wall Street analysts predict an average 1-year price target for ICLR of $362 , with forecasts ranging from a low of $295 to a high of $390 .
ICLR Lowest Price Target Wall Street Target
295 USD 95.58%
ICLR Average Price Target Wall Street Target
362 USD 139.74%
ICLR Highest Price Target Wall Street Target
390 USD 158.57%
Price
Max Price Target
Min Price Target
Average Price Target
400400350350300300250250200200150150May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership ICON Public Limited Company
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
ICON PLC Investors: Please contact the Portnoy Law Firm to recover your losses. April 11, 2025 Deadline to file Lead Plaintiff Motion Investors can contact the law firm at no cost to learn more about recovering their losses globenewswire.com - 1 week ago
Shareholders that Lost Money on ICON Public Limited Company (ICLR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=141579&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
INVESTOR DEADLINE THIS WEEK: ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit SAN DIEGO , April 7, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and January 13, 2025, all dates inclusive (the "Class Period"), have until Friday, April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit.  Captioned Shing v. prnewswire.com - 1 week ago
April 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ICLR NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=141563&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
Levi & Korsinsky Reminds ICON Public Limited Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=141546&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
ICLR DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages ICON plc Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action – ICLR NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”), of the important April 11, 2025 lead plaintiff deadline. globenewswire.com - 1 week ago
Shareholders that lost money on ICON Public Limited Company(ICLR) should contact Levi & Korsinsky about pending Class Action - ICLR NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=141524&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 week ago
Levi & Korsinsky Notifies ICON Public Limited Company Investors of a Class Action Lawsuit and Upcoming Deadline - ICLR NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=141514&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 2 weeks ago
Investors Who Lost Money on ICON Public Limited Company (ICLR) Should Contact Levi & Korsinsky about pending Class Action - ICLR NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=141444&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 2 weeks ago
Investors who lost money on ICON Public Limited Company(ICLR) should contact Levi & Korsinsky about pending Class Action - ICLR NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=141435&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com - 2 weeks ago
ICLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of ICON PLC to Contact the Firm Today! NEW YORK, NY / ACCESS Newswire / April 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC ("ICON" or "the Company") (NASDAQ:ICLR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ICON securities between July 27, 2023 and January 13, 2025, both dates inclusive (the "Class Period"). accessnewswire.com - 2 weeks ago
Class Action Filed Against ICON Public Limited Company (ICLR) Seeking Recovery for Investors - Contact The Gross Law Firm NEW YORK , April 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR). Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. prnewswire.com - 2 weeks ago
8. Profile Summary

ICON Public Limited Company ICLR

image
COUNTRY IE
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 12.2 B
Dividend Yield 0.00%
Description ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Contact South County Business Park, Dublin, 18 https://www.iconplc.com
IPO Date May 15, 1998
Employees 41900
Officers Mr. David Green Vice President of Marketing Mr. Simon Holmes President of Corporate Investments & Partnerships Mr. Diarmaid Cunningham Chief Administrative Officer, General Counsel & Company Secretary Mr. Barry Balfe Chief Operating Officer Ms. Niamh Murphy Director of Corporate Communications Mr. Thomas N. O'Leary Chief Information Officer Mr. Joe Cronin Chief Human Resources Officer Mr. Nigel Clerkin A.C.A. Chief Financial Officer Dr. Steven A. Cutler MBA, Ph.D. Chief Executive Officer & Director Dr. John Climax Ph.D. Founder & Independent Non-Executive Director